CPAP, OSA symptoms, and cardiovascular outcomes
CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea
The New England journal of medicine
Findings: CPAP improved snoring, daytime sleepiness, mood, and health-related quality of life.
Points to consider: Major cardiovascular events were not reduced in this population over an average 3.7 years; average use was 3.3 hours/night.
Device & relevance: CPAP evidence in OSA; the identity of the model offered must be assessed separately from the study findings.